학술논문

Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study
Document Type
article
Source
BMJ Open. 11(7)
Subject
Clinical Research
Pediatric
Perinatal Period - Conditions Originating in Perinatal Period
Infectious Diseases
Prevention
Biodefense
Infant Mortality
Vaccine Related
Emerging Infectious Diseases
Infection
Reproductive health and childbirth
Good Health and Well Being
COVID-19
immunology
neonatology
paediatric infectious disease & immunisation
Clinical Sciences
Public Health and Health Services
Other Medical and Health Sciences
Language
Abstract
ObjectiveTo investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants.DesignA prospective observational study.SettingPublic healthcare system in Santa Clara County (California, USA).ParticipantsWomen with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled between 15 April 2020 and 31 March 2021.OutcomesSARS-CoV-2 serology analyses in the cord and maternal blood at delivery and longitudinally in infant blood between birth and 28 weeks of life.ResultsOf 145 mothers who tested positive for SARS-CoV-2 during pregnancy, 86 had symptomatic infections: 78 with mild-moderate symptoms, and 8 with severe-critical symptoms. The seropositivity rates of the mothers at delivery was 65% (95% CI 0.56% to 0.73%) and the cord blood was 58% (95% CI 0.49% to 0.66%). IgG levels significantly correlated between the maternal and cord blood (Rs=0.93, p